发明名称 |
IMMUNOMODULATION BY IAP INHIBITORS |
摘要 |
PROBLEM TO BE SOLVED: To provide inhibitors of apoptosis protein (IAP) inhibitors that enhance the immune response in a subject when administered to the subject.SOLUTION: Provided is an IAP inhibitor to be used as a medicine for enhancing immune response in a subject, the IAP inhibitor being (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide, or a pharmaceutically acceptable salt thereof. Also provided is a use of the IAP inhibitor to enhance the immune response to cancer, where the immune enhancement includes cytokine production, and the cytokine may be IL-2 or interferon-γ.SELECTED DRAWING: None |
申请公布号 |
JP2016094429(A) |
申请公布日期 |
2016.05.26 |
申请号 |
JP20150236482 |
申请日期 |
2015.12.03 |
申请人 |
NOVARTIS AG;DANA-FARBER CANCER INSTITUTE INC |
发明人 |
LEIGH ZAWEL;MICHAEL DOUGAN;GLENN DRANOFF;BRANT G FIRESTONE;CHRISTOPHER S STRAUB |
分类号 |
A61K31/427;A61P35/00;A61P35/02;A61P37/04;A61P43/00 |
主分类号 |
A61K31/427 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|